These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23363039)

  • 1. Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles.
    Kondej D; Sosnowski TR
    Inhal Toxicol; 2013 Feb; 25(2):77-83. PubMed ID: 23363039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution investigation of nanoparticle interaction with a model pulmonary surfactant monolayer.
    Sachan AK; Harishchandra RK; Bantz C; Maskos M; Reichelt R; Galla HJ
    ACS Nano; 2012 Feb; 6(2):1677-87. PubMed ID: 22288983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant.
    Tatur S; Badia A
    Langmuir; 2012 Jan; 28(1):628-39. PubMed ID: 22118426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant.
    Fan Q; Wang YE; Zhao X; Loo JS; Zuo YY
    ACS Nano; 2011 Aug; 5(8):6410-6. PubMed ID: 21761867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clay nanoparticles on model lung surfactant: a potential marker of hazard from nanoaerosol inhalation.
    Kondej D; Sosnowski TR
    Environ Sci Pollut Res Int; 2016 Mar; 23(5):4660-9. PubMed ID: 26527341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of clay mineral structure and surfactant nature on the adsorption capacity of surfactants by clays.
    Sánchez-Martín MJ; Dorado MC; del Hoyo C; Rodríguez-Cruz MS
    J Hazard Mater; 2008 Jan; 150(1):115-23. PubMed ID: 17532126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical monitoring of bubble size and shape in a pulsating bubble surfactometer.
    Seurynck SL; Brown NJ; Wu CW; Germino KW; Kohlmeir EK; Ingenito EP; Glucksberg MR; Barron AE; Johnson M
    J Appl Physiol (1985); 2005 Aug; 99(2):624-33. PubMed ID: 15790687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adsorption of hematite nanoparticles onto Caco-2 cells and the cellular impairments: effect of particle size.
    Zhang W; Kalive M; Capco DG; Chen Y
    Nanotechnology; 2010 Sep; 21(35):355103. PubMed ID: 20693617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative assessment of inhaled drug particle-pulmonary surfactant interaction by atomic force microscopy.
    Davies MJ; Brindley A; Chen X; Doughty SW; Marlow M; Roberts CJ
    Colloids Surf B Biointerfaces; 2009 Oct; 73(1):97-102. PubMed ID: 19500951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concept to estimate regional inhalation dose of industrially synthesized nanoparticles.
    Koivisto AJ; Aromaa M; Mäkelä JM; Pasanen P; Hussein T; Hämeri K
    ACS Nano; 2012 Feb; 6(2):1195-203. PubMed ID: 22206417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
    Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
    J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of Wyoming montmorillonite surfaces using a cationic surfactant.
    Xi Y; Frost RL; He H; Kloprogge T; Bostrom T
    Langmuir; 2005 Sep; 21(19):8675-80. PubMed ID: 16142947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical Activity of Impaired Lung Surfactant upon Exposure to Polymer Nanoparticles.
    Beck-Broichsitter M
    Langmuir; 2016 Oct; 32(40):10422-10429. PubMed ID: 27641633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.